Evidence map›Paper›PMID 19717841›Full record

ArticleJournal of lipid research2010

Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry.

James G Bollinger, Hiromi Ii, Martin Sadilek, Michael H Gelb

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.Molecules (Basel, Switzerland) · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Lipidomics by ultrahigh performance liquid chromatography-high resolution mass spectrometry and its application to complex biological samples.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James G BollingerDepartment of Chemistry, University of Washington, Seattle, WA, USA.
Hiromi Ii
Martin Sadilek
Michael H Gelb
University of Washington · US

Funding

Biochemical Studies of 14-kDa Phospholipases A2R37HL036235 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 2007 to 2016
$4.1M
Regulation and Function of Cytosolic Phospholipase A2R01HL050040 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 1993 to 2012
$2.4M
STUDIES IN ENZYMOLOGY USING INHIBITORSR01HL036235 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 1989 to 2006
$2.1M
RATIONALLY-DESIGNED INHIBITORS OF PHOSPHOLIPASE-A2R23HL036235 · NHLBI · UNIVERSITY OF WASHINGTON · PI GELB, MICHAEL H · 1986 to 1988
–
NHLBI NIH HHS HL36235NHLBI NIH HHS HL50040NHLBI NIH HHS R01 HL036235NHLBI NIH HHS R01 HL050040NHLBI NIH HHS R37 HL036235
6 · The paper itself

Abstract

LC/ESI-MS/MS has been previously demonstrated to be a powerful method to detect and quantify molecular species of glycerophospholipids including lysophospholipids. In this study, we provide an improved pre-mass spectrometry lipid extraction procedure that avoids the acid-catalyzed decomposition of plasmenyl phospholipids that is problematic with previously reported methods. We show that the use of lysophospholipid internal standards with perdeuterated fatty acyl chains avoids isobar problems associated with the use of internal standards containing odd carbon number fatty acyl chains. We also show that LC prior to MS is required to avoid numerous problems associated with isobars and with MS in-source decomposition of lysophosphatidylserine. The reported method of using normal phase chromatography/ESI-MS is used to quantify lysophospholipids in serum and to quantify lysophospholipids produced in mammalian cells by human group X secreted phospholipase A(2). The latter shows that group X phospholipase A(2) added exogenously to cells generates a different set of lysophospholipids compared with enzyme produced endogenously in cells, which supports earlier studies showing that this phospholipase A(2) can act on cell membranes prior to externalization from cells.

Indexed as

Analytic Sample Preparation MethodsCell LineChromatography, LiquidEthersGene Expression Regulation, EnzymologicGroup X Phospholipases A2HumansLysophospholipidsSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryTime FactorsEthersGroup X Phospholipases A2Lysophospholipids

Identifiers

PMID19717841
PMCPMC2803247
OpenAlexW2046283668

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.